JD Health (06618) launches evidence-based medicine AI product "Zhiyi" to assist doctors in clinical and research scenarios.

12:04 17/01/2026

"Zh y" will be fully integrated into the JD Doctor app, and open to all doctors for experience.

On January 17, 2026, the annual JD Health Doctor Awards Ceremony was held in Beijing. At the event, JD Health unveiled the evidence-based medical AI product "Zhiyi" specially designed for doctors. According to reports, this product focuses on two core scenarios: clinical decision-making and scientific research, deeply integrating millions of authoritative medical data worldwide. It can quickly screen, highly integrate massive authoritative literature and guidelines, and directly output actionable conclusions, improving the quality and efficiency of clinical diagnosis and treatment for doctors, and providing strong support for research exploration. It is reported that "Zhiyi" will be fully integrated into the JD Doctor APP, open for experience for all doctors, whether or not they are part of the JD Internet Hospital, can use this evidence-based medical AI product.

Haisco Pharmaceutical Group (002653.SZ): Innovative drug HSK31679 tablet included in breakthrough therapy program.

Yinbang Clad Material (300337.SZ) is planning to register and issue medium-term notes.

HK Stock Market Move | NATURAL FOOD IH(01837) continues to rise by over 5%, offline channel business significantly grows, with annual net profit increasing by approximately 40% compared to the previous year.

Haisco Pharmaceutical Group (002653.SZ): Innovative drug HSK31679 tablet included in breakthrough therapy program.

Yinbang Clad Material (300337.SZ) is planning to register and issue medium-term notes.